Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 209 entries
Sorted by: Best Match Show Resources per page
Significant cardiac disease complicating Graves' disease in previously healthy young adults.

Endocrinology, diabetes & metabolism case reports

Witczak JK, Ubaysekara N, Ravindran R, Rice S, Yousef Z, Premawardhana LD.
PMID: 31967967
Endocrinol Diabetes Metab Case Rep. 2020 Jan 22;2020. doi: 10.1530/EDM-19-0132. Epub 2020 Jan 22.

SUMMARY: Graves' disease is associated with tachydysrythmia, cardiac ischaemia and cardiomyopathy - all uncommon in young adults without previous cardiac disease. We present three young individuals who developed cardiac complications after periods of uncontrolled Graves' disease. Subject 1: A...

Cite
Witczak JK, Ubaysekara N, Ravindran R, et al. Significant cardiac disease complicating Graves' disease in previously healthy young adults. Endocrinol Diabetes Metab Case Rep. 2020;2020doi: 10.1530/EDM-19-0132.
Witczak, J. K., Ubaysekara, N., Ravindran, R., Rice, S., Yousef, Z., & Premawardhana, L. D. (2020). Significant cardiac disease complicating Graves' disease in previously healthy young adults. Endocrinology, diabetes & metabolism case reports, 2020. https://doi.org/10.1530/EDM-19-0132
Witczak, J K, et al. "Significant cardiac disease complicating Graves' disease in previously healthy young adults." Endocrinology, diabetes & metabolism case reports vol. 2020 (2020). doi: https://doi.org/10.1530/EDM-19-0132
Witczak JK, Ubaysekara N, Ravindran R, Rice S, Yousef Z, Premawardhana LD. Significant cardiac disease complicating Graves' disease in previously healthy young adults. Endocrinol Diabetes Metab Case Rep. 2020 Jan 22;2020. doi: 10.1530/EDM-19-0132. Epub 2020 Jan 22. PMID: 31967967; PMCID: PMC6993248.
Copy Download .nbib Format: NLM
Figure of 3-sign: a case report.

European heart journal. Case reports

Henzel AW, Schwerzmann M.
PMID: 31020238
Eur Heart J Case Rep. 2018 Dec 27;3(1):yty162. doi: 10.1093/ehjcr/yty162. eCollection 2019 Mar.

BACKGROUND: A 50-year-old mother of four children was newly diagnosed with arterial hypertension and bilateral neck pulsations.CASE SUMMARY: Her current blood pressure was 170/100 mmHg in the right arm and 122 mmHg systolic in the right ankle. There was...

Cite
Henzel AW, Schwerzmann M. Figure of 3-sign: a case report. Eur Heart J Case Rep. 2018;3(1):yty162doi: 10.1093/ehjcr/yty162.
Henzel, A. W., & Schwerzmann, M. (2019). Figure of 3-sign: a case report. European heart journal. Case reports, 3(1), yty162. https://doi.org/10.1093/ehjcr/yty162
Henzel, Agata Wiktoria, and Schwerzmann, Markus. "Figure of 3-sign: a case report." European heart journal. Case reports vol. 3,1 (2019): yty162. doi: https://doi.org/10.1093/ehjcr/yty162
Henzel AW, Schwerzmann M. Figure of 3-sign: a case report. Eur Heart J Case Rep. 2018 Dec 27;3(1):yty162. doi: 10.1093/ehjcr/yty162. eCollection 2019 Mar. PMID: 31020238; PMCID: PMC6439367.
Copy Download .nbib Format: NLM
ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation.

ESC heart failure

Srinivasan D, Strohbehn GW, Cascino T.
PMID: 28772029
ESC Heart Fail. 2017 Aug;4(3):384-386. doi: 10.1002/ehf2.12161. Epub 2017 Mar 23.

Angiotensin-converting enzyme inhibitor induced angioedema commonly involves the head and neck area. We report a case of angiotensin-converting enzyme inhibitor induced intestinal angioedema in a heart transplant recipient on mTOR immunosuppression. A 36-year-old Caucasian woman with history of heart...

Cite
Srinivasan D, Strohbehn GW, Cascino T. ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation. ESC Heart Fail. 2017;4(3):384-386doi: 10.1002/ehf2.12161.
Srinivasan, D., Strohbehn, G. W., & Cascino, T. (2017). ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation. ESC heart failure, 4(3), 384-386. https://doi.org/10.1002/ehf2.12161
Srinivasan, Dushyanth, et al. "ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation." ESC heart failure vol. 4,3 (2017): 384-386. doi: https://doi.org/10.1002/ehf2.12161
Srinivasan D, Strohbehn GW, Cascino T. ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation. ESC Heart Fail. 2017 Aug;4(3):384-386. doi: 10.1002/ehf2.12161. Epub 2017 Mar 23. PMID: 28772029; PMCID: PMC5542730.
Copy Download .nbib Format: NLM
Comparative proteinuria management of different angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for normotensive patients with CKD: a Bayesian network meta-analysis.

PeerJ

Ye H, Huo Z, Ye P, Xiao G, Zhang Z, Xie C, Kong Y.
PMID: 32201639
PeerJ. 2020 Mar 12;8:e8575. doi: 10.7717/peerj.8575. eCollection 2020.

BACKGROUND: Both angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are blood pressure-lowering agents, but they are also being used to control proteinuria in early chronic kidney disease (CKD) patients. However, clinically, some patients present merely proteinuria without...

Cite
Ye H, Huo Z, Ye P, et al. Comparative proteinuria management of different angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for normotensive patients with CKD: a Bayesian network meta-analysis. PeerJ. 2020;8:e8575doi: 10.7717/peerj.8575.
Ye, H., Huo, Z., Ye, P., Xiao, G., Zhang, Z., Xie, C., & Kong, Y. (2020). Comparative proteinuria management of different angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for normotensive patients with CKD: a Bayesian network meta-analysis. PeerJ, 8e8575. https://doi.org/10.7717/peerj.8575
Ye, Huizhen, et al. "Comparative proteinuria management of different angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for normotensive patients with CKD: a Bayesian network meta-analysis." PeerJ vol. 8 (2020): e8575. doi: https://doi.org/10.7717/peerj.8575
Ye H, Huo Z, Ye P, Xiao G, Zhang Z, Xie C, Kong Y. Comparative proteinuria management of different angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for normotensive patients with CKD: a Bayesian network meta-analysis. PeerJ. 2020 Mar 12;8:e8575. doi: 10.7717/peerj.8575. eCollection 2020. PMID: 32201639; PMCID: PMC7073241.
Copy Download .nbib Format: NLM
An Unexpected Case of Lisinopril-Associated Severe Hyponatremia.

Cureus

Jiang Y, Cai W, Masquelin ME, Gordon K.
PMID: 32782860
Cureus. 2020 Jul 07;12(7):e9039. doi: 10.7759/cureus.9039.

Angiotensin-converting enzyme (ACE) inhibitors are a class of medications that have formed the backbone of hypertension management. Of these medications, lisinopril is one of the most commonly used. While known serious side effects of all ACE inhibitors include angioedema...

Cite
Jiang Y, Cai W, Masquelin ME, et al. An Unexpected Case of Lisinopril-Associated Severe Hyponatremia. Cureus. 2020;12(7):e9039doi: 10.7759/cureus.9039.
Jiang, Y., Cai, W., Masquelin, M. E., & Gordon, K. (2020). An Unexpected Case of Lisinopril-Associated Severe Hyponatremia. Cureus, 12(7), e9039. https://doi.org/10.7759/cureus.9039
Jiang, Yiran, et al. "An Unexpected Case of Lisinopril-Associated Severe Hyponatremia." Cureus vol. 12,7 (2020): e9039. doi: https://doi.org/10.7759/cureus.9039
Jiang Y, Cai W, Masquelin ME, Gordon K. An Unexpected Case of Lisinopril-Associated Severe Hyponatremia. Cureus. 2020 Jul 07;12(7):e9039. doi: 10.7759/cureus.9039. PMID: 32782860; PMCID: PMC7410512.
Copy Download .nbib Format: NLM
Molecular Changes in miRNA in Irradiated Rat Kidneys: Role of miR-34a and its Vascular Targets in the Notch Pathway.

Radiation research

Gao F, Dong W, Liu P, Narayanan J, Fish BL, Jacobs ER, Medhora M.
PMID: 34330145
Radiat Res. 2021 Dec 01;196(6):611-622. doi: 10.1667/RADE-20-00078.1.

The mechanism(s) of vascular regression in adult organs remains an unexplored gap. Irradiation to the kidney results in vascular regression and renal failure. The goal of this work was to determine molecular mechanism(s) of radiation-induced vascular regression and its...

Cite
Gao F, Dong W, Liu P, et al. Molecular Changes in miRNA in Irradiated Rat Kidneys: Role of miR-34a and its Vascular Targets in the Notch Pathway. Radiat Res. 2021;196(6):611-622doi: 10.1667/RADE-20-00078.1.
Gao, F., Dong, W., Liu, P., Narayanan, J., Fish, B. L., Jacobs, E. R., & Medhora, M. (2021). Molecular Changes in miRNA in Irradiated Rat Kidneys: Role of miR-34a and its Vascular Targets in the Notch Pathway. Radiation research, 196(6), 611-622. https://doi.org/10.1667/RADE-20-00078.1
Gao, Feng, et al. "Molecular Changes in miRNA in Irradiated Rat Kidneys: Role of miR-34a and its Vascular Targets in the Notch Pathway." Radiation research vol. 196,6 (2021): 611-622. doi: https://doi.org/10.1667/RADE-20-00078.1
Gao F, Dong W, Liu P, Narayanan J, Fish BL, Jacobs ER, Medhora M. Molecular Changes in miRNA in Irradiated Rat Kidneys: Role of miR-34a and its Vascular Targets in the Notch Pathway. Radiat Res. 2021 Dec 01;196(6):611-622. doi: 10.1667/RADE-20-00078.1. PMID: 34330145.
Copy Download .nbib Format: NLM
A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database.

Cardiovascular drugs and therapy

Patel NM, Stottlemyer BA, Gray MP, Boyce RD, Kane-Gill SL.
PMID: 33599896
Cardiovasc Drugs Ther. 2021 Feb 18; doi: 10.1007/s10557-021-07157-3. Epub 2021 Feb 18.

PURPOSE: Between 2012 and 2017, the FDA approved 29 therapies for a cardiovascular disease (CVD) indication. Due to the limited literature on patient safety outcomes for recently approved CVD medications, this study investigated adverse drug reports (ADRs) reported in...

Cite
Patel NM, Stottlemyer BA, Gray MP, et al. A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database. Cardiovasc Drugs Ther. 2021;doi: 10.1007/s10557-021-07157-3.
Patel, N. M., Stottlemyer, B. A., Gray, M. P., Boyce, R. D., & Kane-Gill, S. L. (2021). A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database. Cardiovascular drugs and therapy, . https://doi.org/10.1007/s10557-021-07157-3
Patel, Niti M, et al. "A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database." Cardiovascular drugs and therapy vol. (2021). doi: https://doi.org/10.1007/s10557-021-07157-3
Patel NM, Stottlemyer BA, Gray MP, Boyce RD, Kane-Gill SL. A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database. Cardiovasc Drugs Ther. 2021 Feb 18; doi: 10.1007/s10557-021-07157-3. Epub 2021 Feb 18. PMID: 33599896.
Copy Download .nbib Format: NLM
Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure.

Frontiers in physiology

Brown AK, Nichols A, Coley CA, Ekperikpe US, McPherson KC, Shields CA, Poudel B, Cornelius DC, Williams JM.
PMID: 34975523
Front Physiol. 2021 Dec 17;12:765305. doi: 10.3389/fphys.2021.765305. eCollection 2021.

Recently, we reported that obese Dahl salt-sensitive leptin receptor mutant (SS

Cite
Brown AK, Nichols A, Coley CA, et al. Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure. Front Physiol. 2021;12:765305doi: 10.3389/fphys.2021.765305.
Brown, A. K., Nichols, A., Coley, C. A., Ekperikpe, U. S., McPherson, K. C., Shields, C. A., Poudel, B., Cornelius, D. C., & Williams, J. M. (2021). Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure. Frontiers in physiology, 12765305. https://doi.org/10.3389/fphys.2021.765305
Brown, Andrea K, et al. "Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure." Frontiers in physiology vol. 12 (2021): 765305. doi: https://doi.org/10.3389/fphys.2021.765305
Brown AK, Nichols A, Coley CA, Ekperikpe US, McPherson KC, Shields CA, Poudel B, Cornelius DC, Williams JM. Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure. Front Physiol. 2021 Dec 17;12:765305. doi: 10.3389/fphys.2021.765305. eCollection 2021. PMID: 34975523; PMCID: PMC8719629.
Copy Download .nbib Format: NLM
Investigation of inhibition effect of butanol and water extracts of Matricaria chamomilla L. on angiotensin-converting enzyme purified from human plasma.

Biotechnology and applied biochemistry

Bas Z, Turkoglu V, Goz Y.
PMID: 33438805
Biotechnol Appl Biochem. 2021 Jan 13; doi: 10.1002/bab.2106. Epub 2021 Jan 13.

Angiotensin-converting enzyme (ACE) liable for the regulation of blood pressure was purified from human plasma by affinity chromatography. Impact of water and butanol extracts of Matricaria chamomilla L. on purity ACE was examined. ACE was purified using the affinity...

Cite
Bas Z, Turkoglu V, Goz Y. Investigation of inhibition effect of butanol and water extracts of Matricaria chamomilla L. on angiotensin-converting enzyme purified from human plasma. Biotechnol Appl Biochem. 2021;doi: 10.1002/bab.2106.
Bas, Z., Turkoglu, V., & Goz, Y. (2021). Investigation of inhibition effect of butanol and water extracts of Matricaria chamomilla L. on angiotensin-converting enzyme purified from human plasma. Biotechnology and applied biochemistry, . https://doi.org/10.1002/bab.2106
Bas, Zehra, et al. "Investigation of inhibition effect of butanol and water extracts of Matricaria chamomilla L. on angiotensin-converting enzyme purified from human plasma." Biotechnology and applied biochemistry vol. (2021). doi: https://doi.org/10.1002/bab.2106
Bas Z, Turkoglu V, Goz Y. Investigation of inhibition effect of butanol and water extracts of Matricaria chamomilla L. on angiotensin-converting enzyme purified from human plasma. Biotechnol Appl Biochem. 2021 Jan 13; doi: 10.1002/bab.2106. Epub 2021 Jan 13. PMID: 33438805.
Copy Download .nbib Format: NLM
Chaotropic salts impact in HPLC approaches for simultaneous analysis of hydrophilic and lipophilic drugs.

Journal of separation science

Shulyak N, Piponski M, Kovalenko S, Stoimenova TB, Drapak I, Piponska M, Rezk MR, Abbeyquaye AD, Oleshchuk O, Logoyda L.
PMID: 34047016
J Sep Sci. 2021 Aug;44(15):2908-2916. doi: 10.1002/jssc.202100168. Epub 2021 Jun 17.

Simultaneous determination of drugs with different physicochemical properties necessitates thorough research and careful selection of high-performance liquid chromatography conditions. In the present study, various concepts of high-performance liquid chromatography method development for this aim have been discussed. Moreover, the...

Cite
Shulyak N, Piponski M, Kovalenko S, et al. Chaotropic salts impact in HPLC approaches for simultaneous analysis of hydrophilic and lipophilic drugs. J Sep Sci. 2021;44(15):2908-2916doi: 10.1002/jssc.202100168.
Shulyak, N., Piponski, M., Kovalenko, S., Stoimenova, T. B., Drapak, I., Piponska, M., Rezk, M. R., Abbeyquaye, A. D., Oleshchuk, O., & Logoyda, L. (2021). Chaotropic salts impact in HPLC approaches for simultaneous analysis of hydrophilic and lipophilic drugs. Journal of separation science, 44(15), 2908-2916. https://doi.org/10.1002/jssc.202100168
Shulyak, Nataliia, et al. "Chaotropic salts impact in HPLC approaches for simultaneous analysis of hydrophilic and lipophilic drugs." Journal of separation science vol. 44,15 (2021): 2908-2916. doi: https://doi.org/10.1002/jssc.202100168
Shulyak N, Piponski M, Kovalenko S, Stoimenova TB, Drapak I, Piponska M, Rezk MR, Abbeyquaye AD, Oleshchuk O, Logoyda L. Chaotropic salts impact in HPLC approaches for simultaneous analysis of hydrophilic and lipophilic drugs. J Sep Sci. 2021 Aug;44(15):2908-2916. doi: 10.1002/jssc.202100168. Epub 2021 Jun 17. PMID: 34047016.
Copy Download .nbib Format: NLM
Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes.

Frontiers in pharmacology

Gasperetti T, Miller T, Gao F, Narayanan J, Jacobs ER, Szabo A, Cox GN, Orschell CM, Fish BL, Medhora M.
PMID: 34512365
Front Pharmacol. 2021 Aug 25;12:741485. doi: 10.3389/fphar.2021.741485. eCollection 2021.

[This corrects the article DOI: 10.3389/fphar.2021.634477.].

Cite
Gasperetti T, Miller T, Gao F, et al. Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes. Front Pharmacol. 2021;12:741485doi: 10.3389/fphar.2021.741485.
Gasperetti, T., Miller, T., Gao, F., Narayanan, J., Jacobs, E. R., Szabo, A., Cox, G. N., Orschell, C. M., Fish, B. L., & Medhora, M. (2021). Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes. Frontiers in pharmacology, 12741485. https://doi.org/10.3389/fphar.2021.741485
Gasperetti, Tracy, et al. "Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes." Frontiers in pharmacology vol. 12 (2021): 741485. doi: https://doi.org/10.3389/fphar.2021.741485
Gasperetti T, Miller T, Gao F, Narayanan J, Jacobs ER, Szabo A, Cox GN, Orschell CM, Fish BL, Medhora M. Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes. Front Pharmacol. 2021 Aug 25;12:741485. doi: 10.3389/fphar.2021.741485. eCollection 2021. PMID: 34512365; PMCID: PMC8424069.
Copy Download .nbib Format: NLM
Characterization of ACE Inhibitors and AT.

Life (Basel, Switzerland)

Reus P, Schneider AK, Ulshöfer T, Henke M, Bojkova D, Cinatl J, Ciesek S, Geisslinger G, Laux V, Grättinger M, Gribbon P, Schiffmann S.
PMID: 34440554
Life (Basel). 2021 Aug 10;11(8). doi: 10.3390/life11080810.

Blood-pressure-lowering drugs are proposed to foster SARS-CoV-2 infection by pharmacological upregulation of angiotensin-converting enzyme 2 (ACE2), the binding partner of the virus spike (S) protein, located on the surface of the host cells. Conversely, it is postulated that angiotensin-renin...

Cite
Reus P, Schneider AK, Ulshöfer T, et al. Characterization of ACE Inhibitors and AT. Life (Basel). 2021;11(8)doi: 10.3390/life11080810.
Reus, P., Schneider, A. K., Ulshöfer, T., Henke, M., Bojkova, D., Cinatl, J., Ciesek, S., Geisslinger, G., Laux, V., Grättinger, M., Gribbon, P., & Schiffmann, S. (2021). Characterization of ACE Inhibitors and AT. Life (Basel, Switzerland), 11(8), . https://doi.org/10.3390/life11080810
Reus, Philipp, et al. "Characterization of ACE Inhibitors and AT." Life (Basel, Switzerland) vol. 11,8 (2021). doi: https://doi.org/10.3390/life11080810
Reus P, Schneider AK, Ulshöfer T, Henke M, Bojkova D, Cinatl J, Ciesek S, Geisslinger G, Laux V, Grättinger M, Gribbon P, Schiffmann S. Characterization of ACE Inhibitors and AT. Life (Basel). 2021 Aug 10;11(8). doi: 10.3390/life11080810. PMID: 34440554; PMCID: PMC8399150.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 209 entries